Companies Predictimmune

Revealing the likely direction of disease


Understanding patient prognosis in inflammatory disease is a poorly understand process.

Cambridge Innovation Capital is a leading Series A investor in the Cambridge ecosystem.

We were born out of a unique relationship with the University of Cambridge and we maintain privileged access to its most inspiring ideas and people in life sciences and deep tech.

Discover more


Read More